News

Filter

Current filters:

Sanofi PasteurAnti-virals

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

04-11-2014

French drug major Sanofi has reported positive data with its experimental tetravalent dengue vaccine…

Anti-viralsFrancePharmaceuticalResearchSanofi Pasteur

Sanofi Pasteur achieves primary endpoint in Dengue fever vaccine in Latin America trial

Sanofi Pasteur achieves primary endpoint in Dengue fever vaccine in Latin America trial

03-09-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has achieved its primary endpoint…

Anti-viralsDengueDengue feverPharmaceuticalSanofi PasteurSouth AmericaTropical diseases

Sanofi Pasteur announces positive results for Fluzone’s higher dose

Sanofi Pasteur announces positive results for Fluzone’s higher dose

14-08-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has found that Fluzone High-Dose was…

Anti-viralsFluzonePharmaceuticalResearchSanofiSanofi PasteurUSAVaccinationVaccines

US FDA agrees to review Sanofi Pasteur's new quadrivalent influenza vaccine

18-10-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) says it has filed a supplemental Biologics…

Anti-viralsNorth AmericaPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season

17-07-2012

The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

COMPANY SPOTLIGHT

Menarini

Back to top